In vivo self-assembled small RNAs as a new generation of RNAi therapeutics
2021 · Cell Research · 119 citations
https://doi.org/10.1038/s41422-021-00491-z
M
Mengchao Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.5K
Citations
23
h-index
30
i10-index
Mengchao Yu is an academic researcher from Qingdao University. The author has contributed to research in topics: MicroRNA in disease regulation & RNA modifications and cancer & Circular RNAs in diseases. The author has an h-index of 23, co-authored 41 publications.
ORCID: 0000-0002-2535-429XPapers by this author
worksmiR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B
2018 · Cell Death and Disease · 91 citations
https://doi.org/10.1038/s41419-018-0611-0
<scp>PTP</scp>1B markedly promotes breast cancer progression and is regulated by miR‐193a‐3p
2018 · FEBS Journal · 74 citations
https://doi.org/10.1111/febs.14724
HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer
2016 · Cell Death and Differentiation · 39 citations
https://doi.org/10.1038/cdd.2016.136
ING5 suppresses breast cancer progression and is regulated by miR-24
2017 · Molecular Cancer · 33 citations
https://doi.org/10.1186/s12943-017-0658-z
In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis
2022 · Nature Communications · 33 citations
https://doi.org/10.1038/s41467-022-33436-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat